Research Study

Optimize Risk Assessment for Incident and Recurrent Atherosclerotic Cardiovascular Disease

The current US atherosclerotic cardiovascular disease (ASCVD) risk prediction tools are limited by failing to include data on social determinants of health (SDOH) and important US ethnic groups. The overall goal of this project is to improve ASCVD risk assessment for both primary and secondary prevention by drawing from more contemporary data sources. Results of this study will improve lipid-lowering therapy use and may reduce health inequities.

Principal Investigator:

Jaejin An, PhD

Funding Source:

National Heart, Lung, and Blood Institute (NHLBI)

Funding Years:

2021 - 2026